Fractyl Health, Inc. (GUTS)
NASDAQ: GUTS · Real-Time Price · USD
0.5914
+0.0289 (5.14%)
Sep 17, 2026, 10:08 AM EDT - Market open
Fractyl Health Stock Forecast
Stock Price Forecast
According to 7 analysts polled by S&P Global, Fractyl Health stock has a consensus rating of "Strong Buy" and an average price target of $5.03. The average 1-year stock price forecast is 750.52% higher than the current stock price, while the lowest is $2.00 (+238.18%) and the highest is $8.00 (+1,252.72%).
Price Target: $5.03 (+750.52%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Fractyl Health stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 | Sep '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 5 | 6 | 6 | 6 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 6 | 7 | 7 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Craig-Hallum | Craig-Hallum | Buy Maintains $4 | Buy | Maintains | $4 | +576.36% | Sep 2, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Maintains $8 | Buy | Maintains | $8 | +1,252.72% | Sep 2, 2026 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $2 | Hold | Maintains | $2 | +238.18% | Sep 1, 2026 |
| Canaccord Genuity | Canaccord Genuity | Buy Maintains $8 | Buy | Maintains | $8 | +1,252.72% | Aug 12, 2026 |
| Bank of America Securities | Bank of America Securities | Buy Reiterates $2 | Buy | Reiterates | $2 | +238.18% | Aug 11, 2026 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
22.38M
EPS This Year
-0.33
from -1.86
EPS Next Year
-0.44
from -0.33
EPS and Forward PE are based on non-GAAP adjusted numbers.